<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 15.6: Advanced Lipidology and Cardiovascular Nutrition</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Cardiovascular */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e40af;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
            background: #f0f4ff;
            padding: 2px 6px;
            border-radius: 4px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #1e3a8a;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Data Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f4ff;
            border-radius: 8px;
            color: #1e40af;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 12px;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #fafafa;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #1e3a8a;
        }

        .references-box ul {
            padding-left: 20px;
            list-style-type: decimal;
        }

        .references-box li {
            margin-bottom: 10px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 15: Advanced Clinical Deep Dives</p>
            <h1 class="lesson-title">Lesson 15.6: Advanced Lipidology and Cardiovascular Nutrition</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è± 35 min read</span>
                <span class="meta-item">üéì Level: Expert</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Beyond LDL-C: The ApoB Era</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Lipoprotein Subfractions (Pattern A vs B)</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Oxidized LDL & Inflammation</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Endothelial Glycocalyx</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Advanced Nutritional Strategies</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Interpreting CAC and CIMT Scans</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between standard lipid panels and advanced markers like ApoB and Lp(a).</li>
                <li>Explain the physiological significance of LDL particle size and density (Pattern A vs. Pattern B).</li>
                <li>Analyze the role of oxidative stress and the endothelial glycocalyx in plaque formation.</li>
                <li>Apply targeted nutritional protocols (fiber, sterols, Omega-3s) to optimize cardiovascular markers.</li>
                <li>Evaluate cardiovascular risk using advanced imaging data (CAC and CIMT).</li>
            </ul>
        </div>

        <h2 id="section1">1. Beyond LDL-C: The ApoB Era</h2>
        <p>For decades, the "Total Cholesterol" and "LDL-C" metrics have been the primary focus of cardiovascular risk assessment. However, current research indicates that these markers are often insufficient. LDL-C measures the <i>mass</i> of cholesterol within low-density lipoproteins, but it does not account for the <i>number</i> of particles carrying that cholesterol.</p>

        <p>Within the <span class="highlight">N.O.U.R.I.S.H. Method‚Ñ¢</span>, specifically the <b>U: Uncover Root Causes</b> phase, we look deeper at <span class="highlight">Apolipoprotein B (ApoB)</span>. Every atherogenic particle‚Äîincluding LDL, VLDL, and IDL‚Äîcarries exactly one molecule of ApoB. Therefore, ApoB provides a direct count of the total number of potentially plaque-forming particles in circulation.</p>

        <p>A 2019 meta-analysis published in <i>JAMA Cardiology</i> involving over <span class="stat-highlight">400,000 participants</span> demonstrated that for every standard deviation increase in ApoB, the risk of coronary artery disease increased by 61%, even when LDL-C levels were controlled for. This suggests that the particle count (ApoB) is a more potent driver of risk than the cholesterol concentration (LDL-C).</p>

        <h2 id="section2">2. Lipoprotein Subfractions (Pattern A vs. Pattern B)</h2>
        <p>Not all LDL particles are created equal. Advanced lipidology categorizes particles based on their size and density. This is crucial because smaller, denser particles are more likely to penetrate the arterial wall and become oxidized.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Pattern A (Large Buoyant)</th>
                        <th>Pattern B (Small Dense)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Particle Size</strong></td>
                        <td>Large, "fluffy" particles</td>
                        <td>Small, compact particles</td>
                    </tr>
                    <tr>
                        <td><strong>Atherogenicity</strong></td>
                        <td>Low (less likely to penetrate endothelium)</td>
                        <td>High (easily trapped in arterial wall)</td>
                    </tr>
                    <tr>
                        <td><strong>Metabolic Context</strong></td>
                        <td>Often seen with low triglycerides/insulin sensitivity</td>
                        <td>Associated with insulin resistance/high TG</td>
                    </tr>
                    <tr>
                        <td><strong>Risk Profile</strong></td>
                        <td>Lower risk for CVD</td>
                        <td>3x higher risk for Myocardial Infarction</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Furthermore, we must address <span class="highlight">Lipoprotein(a) [Lp(a)]</span>. This is a genetically determined particle similar to LDL but with an added protein (apolipoprotein a) that makes it highly pro-thrombotic and pro-inflammatory. Approximately <span class="stat-highlight">20% of the world's population</span> has elevated Lp(a), which remains largely unaffected by standard dietary changes, requiring targeted integrative strategies.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The "Lean Mass Hyper-Responder"</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.8)">Lipid Discordance Analysis</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">D</div>
                    <div class="patient-info">
                        <h4>David, 44</h4>
                        <p>Triathlete, Low-Carbohydrate Diet, LDL-C: 210 mg/dL</p>
                    </div>
                </div>
                <p><b>Presenting Symptoms:</b> David was concerned about his "dangerously high" LDL-C of 210 mg/dL despite being metabolically healthy (HbA1c: 4.9%, TG: 45 mg/dL, HDL: 85 mg/dL).</p>
                <p><b>Intervention:</b> We ordered an NMR LipoProfile to assess particle size. David showed a distinct <b>Pattern A</b> profile with very low ApoB relative to his LDL-C. His CAC (Calcium Score) was 0.</p>
                <p><b>Outcome:</b> By identifying that his high LDL-C was composed of large, buoyant particles and that his inflammatory markers (hs-CRP < 0.5) were optimal, we determined his risk was significantly lower than his standard lipid panel suggested. We focused on maintaining <span class="highlight">metabolic flexibility</span> rather than aggressive lipid-lowering drugs.</p>
            </div>
        </div>

        <h2 id="section3">3. Oxidized LDL & Inflammation</h2>
        <p>Cholesterol itself is not the "enemy"; it is a vital structural component of cell membranes and a precursor to hormones. The danger arises when LDL particles become <span class="highlight">oxidized (oxLDL)</span>. When an LDL particle stays in circulation too long (common in insulin resistance) or is exposed to high levels of systemic oxidative stress, its polyunsaturated fatty acids are damaged.</p>

        <p>Oxidized LDL is not recognized by the standard LDL receptors. Instead, it is taken up by "scavenger receptors" on macrophages, leading to the formation of <span class="highlight">foam cells</span>‚Äîthe hallmark of atherosclerotic plaque. This process is driven more by <b>high-sugar diets</b> and <b>chronic inflammation</b> than by dietary saturated fat intake alone.</p>

        <h3>The Role of Glycation</h3>
        <p>As discussed in Lesson 15.1 (Glycemic Variability), high blood glucose levels lead to the glycation of proteins. When the ApoB protein on an LDL particle becomes glycated, its half-life increases significantly, providing more opportunity for oxidation. This is why diabetics have such high rates of CVD even with "normal" LDL-C levels.</p>

        <h2 id="section4">4. The Endothelial Glycocalyx</h2>
        <p>The <span class="highlight">Endothelial Glycocalyx</span> is a microscopic, gel-like layer of glycoproteins and proteoglycans that lines the entire cardiovascular system. Think of it as the "non-stick coating" of your arteries. It regulates vascular permeability, prevents leukocyte adhesion, and signals the production of <b>Nitric Oxide (NO)</b>.</p>

        <p>When the glycocalyx is healthy, LDL particles‚Äîeven small dense ones‚Äîstruggle to stick to the arterial wall. However, the glycocalyx is extremely fragile. It can be "shed" or damaged within minutes by:</p>
        <ul>
            <li>Hyperglycemia (Post-prandial glucose spikes)</li>
            <li>Oxidative stress (Smoking, environmental toxins)</li>
            <li>Systemic inflammation (Elevated TNF-alpha)</li>
        </ul>

        <p>In the <b>I: Integrative Protocols</b> phase of the NOURISH Method‚Ñ¢, we prioritize glycocalyx restoration through the use of <span class="highlight">R-Alpha Lipoic Acid</span>, seaweed-derived glucosaminoglycans, and nitrate-rich vegetables to support nitric oxide synthesis.</p>

        <h2 id="section5">5. Nutritional Strategies for Lipid Optimization</h2>
        <p>While the "low-fat" era has passed, specific nutritional interventions remain powerful tools for modifying lipid profiles and reducing cardiovascular risk.</p>

        <h3>Soluble Fiber & Phytosterols</h3>
        <p>Soluble fiber (found in oats, legumes, and psyllium) binds to bile acids in the intestine, forcing the liver to pull LDL from the blood to produce more bile. A meta-analysis of 28 trials found that <span class="stat-highlight">5-10g of soluble fiber per day</span> reduces LDL-C by approximately 5-10%.</p>

        <h3>Omega-3 Fatty Acids (EPA/DHA)</h3>
        <p>Omega-3s do not significantly lower LDL-C, but they are potent at lowering <span class="highlight">Triglycerides</span> and reducing the inflammatory potential of the blood. The <i>REDUCE-IT</i> trial (2019) demonstrated that high-dose purified EPA (4g/day) resulted in a <span class="stat-highlight">25% reduction</span> in major adverse cardiovascular events in high-risk patients.</p>

        <h3>The Portfolio Diet Approach</h3>
        <p>Integrating multiple lipid-lowering foods simultaneously‚Äîsoy protein, almonds, plant sterols, and soluble fiber‚Äîhas been shown to be as effective as first-generation statins in some populations, reducing LDL-C by up to 30%.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: Metabolic Syndrome & Pattern B</p>
                    <p style="margin:0; font-size:13px; color:rgba(255,255,255,0.8)">The Power of Fiber and Carbohydrate Restriction</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Maria, 58</h4>
                        <p>Pre-diabetic, High Triglycerides (240 mg/dL), Pattern B</p>
                    </div>
                </div>
                <p><b>The Challenge:</b> Maria's lipid panel showed "moderate" LDL-C (130 mg/dL) but very high Triglycerides and low HDL (38 mg/dL). NMR testing confirmed a high concentration of small, dense LDL particles.</p>
                <p><b>The Protocol:</b> We implemented the <b>R: Restore Balance</b> phase, focusing on glycemic control. We reduced processed carbohydrates and added 10g of psyllium husk and 3g of EPA/DHA daily.</p>
                <p><b>Results:</b> In 12 weeks, Maria's triglycerides dropped to 110 mg/dL, and her LDL shifted from <b>Pattern B to Pattern A</b>. Her ApoB dropped by 18%.</p>
            </div>
        </div>

        <h2 id="section6">6. Interpreting Cardiovascular Risk Scans</h2>
        <p>Lipid markers are <i>proxies</i> for risk; imaging provides evidence of <i>actual disease</i>. As a Holistic Nutrition Coach, understanding these scans allows you to tailor the intensity of your nutritional protocols.</p>

        <h3>CAC (Coronary Artery Calcium) Score</h3>
        <p>A CAC scan is a specialized CT scan that measures calcified plaque in the coronary arteries. It is the single most powerful predictor of future cardiovascular events.
        <ul>
            <li><b>Score 0:</b> Extremely low risk (the "power of zero").</li>
            <li><b>Score 1-100:</b> Mild plaque; warrants significant lifestyle intervention.</li>
            <li><b>Score 400+:</b> High risk; requires aggressive integrative management.</li>
        </ul>
        </p>

        <h3>CIMT (Carotid Intima-Media Thickness)</h3>
        <p>Unlike the CAC, which only sees <i>hardened</i> (calcified) plaque, the CIMT uses ultrasound to measure the thickness of the carotid artery walls. It can detect "soft" plaque, which is more vulnerable to rupture. This is a vital tool for younger clients where calcification may not have occurred yet.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is ApoB considered a superior marker to LDL-C for predicting cardiovascular risk?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    ApoB measures the total number of atherogenic particles (LDL, VLDL, IDL). Since each particle contains one ApoB molecule, it provides a particle count, which is a better predictor of the likelihood of particles entering the arterial wall than the total mass of cholesterol (LDL-C).
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary danger of "Pattern B" LDL particles compared to "Pattern A"?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Pattern B particles are smaller and denser, making them more likely to penetrate the endothelial lining, become trapped in the sub-endothelial space, and undergo oxidation, which triggers the inflammatory plaque-building process.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><b>Focus on ApoB:</b> Particle count is more predictive than cholesterol volume (LDL-C).</li>
                <li><b>Address Oxidation:</b> Reducing systemic inflammation and glycation is as important as managing lipid levels.</li>
                <li><b>Protect the Glycocalyx:</b> This "non-stick" lining is the first line of defense against atherosclerosis.</li>
                <li><b>Personalize by Pattern:</b> Use NMR or Ion Mobility testing to determine if a client has Pattern A (lower risk) or Pattern B (higher risk).</li>
                <li><b>Imaging Matters:</b> Use CAC and CIMT scores to validate the effectiveness of nutritional protocols and assess real-world risk.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Ference, B. A., et al. (2017). "Low-density lipoproteins cause atherosclerotic cardiovascular disease." <i>European Heart Journal</i>.</li>
                <li>Sniderman, A. D., et al. (2019). "Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review of Recent Evidence." <i>JAMA Cardiology</i>.</li>
                <li>Bhatt, D. L., et al. (2019). "Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia (REDUCE-IT)." <i>New England Journal of Medicine</i>.</li>
                <li>Grundy, S. M., et al. (2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." <i>Journal of the American College of Cardiology</i>.</li>
                <li>Nordestgaard, B. G., et al. (2020). "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis." <i>The Lancet</i>.</li>
                <li>Estruch, R., et al. (2018). "Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts (PREDIMED)." <i>New England Journal of Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Holistic Nutrition Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved.</p>
        </footer>
    </div>
</body>

</html>